新生儿髋关节不稳定的长期随访:治疗后的临床转归
一项基于人群的长期随访研究比较了新生儿期因髋关节不稳定接受Von Rosen类支具治疗的患者与年龄性别匹配对照的髋关节相关生活质量与临床检查结果。平均随访18.2年,组间HAGOS评分仅症状亚量表差异有统计学意义,但治疗组在屈髋内收内旋试验、抗阻直腿抬高试验阳性率及被动髋屈曲终末腹股沟疼痛方面均高于对照。结论认为治疗组临床检查更易出现髋部不适,但疼痛体验、身体功能和髋相关生活质量无临床相关差异。
要点
- 新生儿髋关节不稳定治疗后18年,HAGOS评分仅症状亚量表差异有统计学意义(平均差3.80,95%CI 0.31-7.29;p=0.033)。
- 治疗组屈髋内收内旋试验阳性率(OR 2.6,95%CI 1.2-5.6;p=0.014)和抗阻直腿抬高试验阳性率(OR 4.5,95%CI 1.4-14.9;p=0.014)高于对照。
- 治疗组被动髋屈曲终末腹股沟疼痛更常见(OR 2.5,95%CI 1.2-5.3;p=0.015),但疼痛体验、身体功能和髋相关生活质量无临床相关差异。
核心结论
- 新生儿髋关节不稳定治疗后18年随访中,临床检查更易出现髋部不适,但疼痛体验、身体功能和髋相关生活质量与匹配对照无临床相关差异。
研究设计与样本
- 基于人群的长期随访研究,纳入1995至2001年在本院因新生儿髋关节不稳定接受Von Rosen类支具治疗(1月龄前开始)的患者96例(75.6%),并招募年龄性别匹配对照94例。
主要发现
- 平均随访18.2年(14.6至22.0年),组间HAGOS评分相似,仅症状亚量表差异有统计学和临床意义(平均差3.80,95%CI 0.31至7.29;p=0.033)。
- 治疗组屈髋内收内旋试验阳性频率更高(OR 2.6,95%CI 1.2至5.6;p=0.014)。
- 治疗组抗阻直腿抬高试验阳性频率更高(OR 4.5,95%CI 1.4至14.9;p=0.014)。
- 治疗组被动髋屈曲终末腹股沟疼痛更常见(OR 2.5,95%CI 1.2至5.3;p=0.015)。
临床怎么用
- 对新生儿期髋关节不稳定经支具治疗后的长期随访,应关注屈髋内收内旋试验、抗阻直腿抬高试验及被动髋屈曲终末疼痛等临床检查指标。
- 尽管临床检查阳性率较高,但患者报告的疼痛、身体功能和髋相关生活质量与对照无临床相关差异,解读检查结果时需结合患者报告结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: We aimed to determine hip-related quality of life and clinical findings following treatment for neonatal hip instability (NHI) compared with age- and sex-matched controls. We hypothesized that NHI would predispose to hip discomfort in long-term follow-up. METHODS: We invited those born between 1995 and 2001 who were treated for NHI at our hospital to participate in this population-based study. We included those that had Von Rosen-like splinting treatment started before one month of age. A total of 96 patients treated for NHI (75.6 %) were enrolled. A further 94 age- and sex-matched controls were also recruited. The Copenhagen Hip and Groin Outcome Score (HAGOS) questionnaire was completed separately for both hips, and a physical examination was performed. RESULTS: The mean follow-up was 18.2 years (14.6 to 22.0). The HAGOS scores between groups were similar and met statistical and clinical significance only in the Symptoms subscale (mean difference 3.80, 95% confidence interval (CI) 0.31 to 7.29; p = 0.033). Those patients who had undergone treatment for NHI had a higher frequency of positive flexion-adduction-internal rotation test (odds ratio (OR) 2.6, 95% CI 1.2 to 5.6; p = 0.014), resisted straight leg rise test (OR 4.5, 95% CI 1.4 to 14.9; p = 0.014), and also experienced more pain in the groin during passive end range hip flexion (OR 2.5, 95% CI 1.2 to 5.3; p = 0.015) than controls. CONCLUSION: NHI predisposes to hip discomfort in clinical tests, but no clinically relevant differences in experience of pain, physical function, and hip-related quality of life could be observed between the treated group and matched controls in 18 years of follow-up. Cite this article: Bone Joint J 2020;102-B(12):1767-1773.
引用
- Maikku M, Ohtonen P, Valkama M, et al. Treatment outcome of neonatal hip instability. Bone Joint J. 2020. PMID: 33249896. doi:10.1302/0301-620X.102B12.BJJ-2020-0266.R2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。